IRIS - Res&Arch Institutional Research Information System - Research & Archive

IORIO, Anna Maria
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.627
EU - Europa 1.283
AS - Asia 469
AF - Africa 1
Totale 3.380
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.609
IE - Irlanda 377
UA - Ucraina 368
HK - Hong Kong 178
VN - Vietnam 157
IT - Italia 114
SE - Svezia 94
FI - Finlandia 92
DE - Germania 69
RU - Federazione Russa 64
CN - Cina 54
TR - Turchia 38
GB - Regno Unito 28
BE - Belgio 23
KR - Corea 15
CA - Canada 13
FR - Francia 12
SG - Singapore 12
CH - Svizzera 10
NL - Olanda 8
LB - Libano 7
UZ - Uzbekistan 7
AT - Austria 5
GR - Grecia 5
MX - Messico 5
PL - Polonia 5
RO - Romania 4
CZ - Repubblica Ceca 3
ES - Italia 1
GH - Ghana 1
IN - India 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 3.380
Salva come PNG Salva come JPEG
Città #
Chandler 383
Dublin 377
Jacksonville 214
San Mateo 181
Hong Kong 178
Dong Ket 157
Ann Arbor 93
Medford 77
Princeton 77
Wilmington 55
Andover 48
Izmir 38
Beijing 37
Perugia 29
Des Moines 24
Saint Petersburg 21
Brussels 20
Altamura 17
Genoa 17
Helsinki 16
Norwalk 15
Woodbridge 15
Dongjak-gu 14
Ottawa 12
Lawrence 10
Redwood City 10
Los Angeles 9
Boardman 8
Houston 8
Singapore 8
Shanghai 7
Redmond 6
Falls Church 5
Ashburn 4
Auburn Hills 4
Den Haag 4
Corciano 3
Dearborn 3
Heusden 3
Milan 3
Moscow 3
Sona 3
Terni 3
Amsterdam 2
Cuernavaca 2
Faenza 2
Frankfurt Am Main 2
New York 2
Philadelphia 2
Pistoia 2
Timisoara 2
Turin 2
Andra 1
Augusta 1
Bratislava 1
Bucharest 1
Como 1
Costa Mesa 1
Florence 1
Hanover 1
Lenzburg 1
Madrid 1
Messina 1
Mexico 1
Miami 1
Muenster 1
Nanchang 1
Rome 1
San Jose 1
San Paolo di Civitate 1
Seattle 1
Seoul 1
Solon 1
St Petersburg 1
Stockholm 1
Tempio Pausania 1
Toronto 1
Vienna 1
Warsaw 1
Totale 2.264
Salva come PNG Salva come JPEG
Nome #
Antibody response and protection after intradermal and intramuscular 2011/2012 trivalent influenza vaccination in elderly volunteers 83
"Immunogenicity of the MF-59-adjuvanted influenza vaccine in volunteers of different groups of age" 4th National Congress of the Italian Society of Virology (SIV) 82
An influenza A/H3N2 outbreak during the 2004/05 winter in elderly vaccinated people living in a nursing home 78
Immunogenicità ed efficacia protettiva del vaccino influenzale per l’inverno 2007/08 in soggetti anziani residenti in casa di riposo” 36° Congresso Nazionale della Società Italiana di Microbiologia 77
" MF-59-adjuvanted influenza vaccine: immunogenicity and protection in adult and elderly volunteers (winter season 2003/2004)" 76
I benefici della vaccinazione influenzale Analisi e prospettive nella popolazione non anziana a rischio 76
Effect of age on serum heterologous antibody response elicited by inactivated influenza virus vaccine” 7th National Congress of the Italian Society of Virology 71
Antibody Responses after Influenza Vaccination in Elderly People: Useful Information from a 27-Year Study (from 1988–1989 to 2014–2015) 70
Annually repeated influenza vaccination and humoral response in elderly volunteers. 67
Antibody responses and HIV-1 viral load in HIV-1-seropositive subjects immunised with either the MF59 adjuvanted influenza vaccine or a conventional non-adjuvanted subunit vaccine during highly active antiretroviral therapy. 64
An influenza A/H3 outbreak during the 2004/05 winter in elderly vaccinated people living in a nursing home. 62
An influenza A/H3 outbreak during the 2004/2005 winter in elderlyvaccinated people living in a nursing home 59
An influenza B outbreak in elderly vaccinated people in the winter season 2007/2008” The Third European Influenza Conference 58
[Colony inhibition test (C.I.T.) and the cytotoxic adherence test (C.A.T.): some comparative data]. 58
Influenza vaccine immunogenicity and efficacy in istitutionalized elderly volunteers (winter season 2002/03). 57
Immunogenicity of the MF-59-adjuvanted influenza vaccine in volunteers of different groups of age. 56
Antibody response against unchanged influenza vaccine components in elderly people vaccinated in consecutive years 56
Proceedings of the X National Biotechnology Congress. 54
Influenza B virus circulation in elderly vaccinated people living in a nursing home in the winter season 2007/2008” 8th National Congress of the Italian Society of Virology 53
Induzione di risposta immunitaria e di protezione da parte dei vaccini antinfluenzali in soggetti anziani. 53
Interaction Between Influenza Vaccination and Oral Anticoagulant Therapy: A Randomized Blinded Clinical Trial. 53
Influenza vaccination in patients on long-term anticoagulant therapy 53
Differente risposta anticorpale al vaccine anti-influenzale per l’inverno 2008/2009 in soggetti anziani residenti in due differenti case di riposo. 52
An observational retrospective study provide information on hospitalization and severe outcomes of the 2009 A(H1N1) infection in Italy. 52
Cross-reactive antibodies in middle-aged and elderly volunteers after MF59-adjuvanted subunit trivalent influenza vaccine against B viruses of the B/Victoria or B/Yamagata lineages 51
[Natural resistance and induced resistance to ATPC + tumor in mice]. 50
Immunobiological aspects of the nude mouse model relative to human cancer chemosensitivity tests. 50
Influenza vaccine induced antibody response against B influenza viruses included in the vaccine or naturally circulating during the winter season 2010/2011 50
Pandemic Influenza A/H1N1pdm in Italy: Age, Risk and Population Susceptibility 50
Antibody response elicited by 2012/2013 “implemented influenza vaccines”, FLUAD® (Novartis Vaccines & Diagnostics) and INTANZA® 15Mcg (Sanofi Pasteur MSD), in chronically ill institutionalized elderly volunteers 50
A 21-winter seasons retrospective study of antibody response after influenza vaccination in elderly (60–85 years old) and very elderly (>85 years old) institutionalized subjects 49
The effect of influenza vaccination in patients on long-term oral anticoagulant therapy 47
Induction of cross-reactive antibodies to 2009 pandemic H1N1 influenza virus (pH1N1) after seasonal vaccination (winters 2003/04 and 2007/08). 47
Immunogenicity of conventional trivalent inactivated influenza vaccines in pre-vaccination unprotected elderly volunteers in five winters seasons. 45
Effects of repeated annual influenza vaccination on antibody responses against unchanged vaccine antigens in elderly frail institutionalized volunteers. 45
An influenza B outbreak during the 2007/2008 winter among appropriately immunized elderly people living in a nursing home. 43
Radioresistant Inhibition of Tumors (RIT): Biological and Pharmacological Studies 43
Induction of Cross-Reactive Antibodies to 2009 Pandemic H1N1 Influenza Virus (pH1N1) After Seasonal Vaccination (Winters 2003/04 and 2007/08) 43
Influenza vaccination and vitamin K antagonist treatment: a placebo-controlled, randomized, double-blind crossover study. 43
Cross-reactive antibodies to viruses of both B/Victoria and B/Yamagata lineages as induced by influenza vaccination in middle-aged and elderly volunteers 42
MF-59-adjuvanted influenza vaccine: immunogenicity and protection in adult and enderly volunteers (winter season 2003/04). 42
The intersubunit region of influenza virus haemagglutinin as a peptide vaccine candidate. 42
Synthesis and immuno-characterization of HSV-1 peptides for a potential vaccine 41
Immunization with adjuvanted and non-adjuvanted influenza vaccines of HIV-1 positive patients treated with highly active antiretroviral therapy (HAART) 41
Immunogenicity of the MF-59-adjuvanted vaccine in volunteers of different group of age. 41
Comparative study on immunogenicity among split, intradermal and MF59-adjuvanted influenza vaccines in elderly institutionalized subjects 41
Clinical characteristics of influenza A/H1N1, A/H3N2 and B infections in children during three consecutive winter seasons (2012-13, 2013-14 and 2014-15) 41
Partial Protection Induced by 2011–2012 Influenza Vaccine Against Serologically Evidenced A(H3N2) Influenza Virus Infections in Elderly Institutionalized People 41
[The serum protein picture in mice with ATPC ascites tumors studied by means of disk electrophoresis]. 40
Hospitalization associated with 2009 pandemic influenza A(H1N1) infection in Umbria, a region of central Italy, July – December 2009. 39
Pro-inflammatory cytokines/ chemokines production after infection of A549 Human epithelial cell line with different strains of human influenza viruses 39
Declined antibody response following influenza vaccination in elderly as compared with middle-aged volunteers: effects of aging and/or original antigenic sin? 38
Pentraxin 3 protects from MCMV infection and reactivation through TLR sensing pathways leading to IRF3 activation. 37
Seroprevalence against pandemic influenza A(H1N1) 2009 after the first season of circulation in Italy 37
VALUTAZIONE DELL’EFFICACIA PROTETTIVA E DELLA CAPACITA’ DI INDURRE ANTICORPI CROSS-REATTIVI NEI CONFRONTI DI VIRUS INFLUENZALI DI TIPO B APPARTENENTI AI LINEAGGI YAMAGATA E VICTORIA DA PARTE DI DUE VACCINI INFLUENZALI TRIVALENTI (FLUAD® E INTANZA®) IN ANZIANI ISTITUZIONALIZZATI 37
Immunogenicity of influenza vaccine (1993-94 winter season) in HIV-seropositive and -seronegative ex-intravenous drug users. 36
Influenza vaccine induction of cross–reactive antibodies against different B/Yamagata and B/Victoria-like influenza viruses. , 36
Comparative study of immunogenicity of split, intradermal and MF59-adjuvanted influenza vaccines in elderly institutionalized subjects 35
Increased immunogenicity of an adjuvanted influenza vaccine compared with a conventional subunit vaccine in non-elderly adult HIV seropositive individuals, treated with HAART 34
Sorveglianza delle paralisi flaccide acute nella regione Umbria 34
[Selective inhibition of the response to the allograft of a virus in mice] 33
Influenza A virus specific T cell immunity in humans during ageing 32
Seroprevalence to the 2009 pandemic influenza a(H1N1) virus in the italian population after the 2009 pandemic (September/November 2010) 32
Soggetti ricoverati in ospedale in Umbria con diagnosi di laboratorio di infezione da virus influenzale pandemico A/H1N1 nel periodo Luglio 2009 - Marzo 2010 32
Immunogenicity of intramuscular MF59-adjuvanted and intradermal administered influenza enhanced vaccines in subjects aged over 60: A literature review 32
Serologically diagnosed influenza virus A/California/7/04 (H3N2)infection in people immunised with A/Fujan/411/2002(H3N2)antigen during the 2004/05 winter season 31
Laboratory confirmed pandemic H1N1 influenza virus infections in hospitalization in Umbria, a region of central Italy (May-November 2009). 31
Intradermal and intramuscular 2011-2012 influenza vaccination of elderly institutionalized volunteers: induction of antibody responses against vaccine and epidemic influenza virus strains 31
Influenza vaccination in patients on long-term anticoagulant therapy 30
Twenty-seven years experience with immunogenicity of inactivated influenza vaccines in the elderly 30
The new pandemic A/H1N1 influenza virus (pH1N1): celluler and humoral cross-reactive immune responses induced in healthy adults following 2007/2008 influenza vaccination. 29
Induzione di anticorpi omologhi e cross-reattivi nei confronti di virus influenzali di tipo B da parte del vaccino influenzale nell'inverno 2003/2004 28
Influenza viruses and cross-reactivity in healthy adults: humoral and cellular immunity induced by seasonal 2007/2008 influenza vaccination against vaccine antigens and 2009 A(H1N1) pandemic influenza virus 27
Sorveglianza molecolare delle gastroenteriti da rotavirus in Umbria 24
ENDOGENOUS INTERLEUKYN-6 LEVELS AND ANTIBODY RESPONSE TO INACTIVATED INFLUENZA VACCINE IN PLURIVACCINATED ELDERLY VOLUNTEERS 22
Factors influencing humoral immune response after influenza vaccination in elderly and very elderly subjects 20
Serological evidence of partial protection against infection with A/H3N2 circulating drifted strains after immunization with enhanced 2011/2012 trivalent influenza vaccines 15
Totale 3.519
Salva come PNG Salva come JPEG
Categoria #
all - tutte 12.364
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.364
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201943 0 0 0 0 0 0 0 0 0 0 43 0
2019/2020330 6 2 53 5 54 3 57 17 60 35 9 29
2020/2021751 14 57 10 61 207 23 74 3 65 14 61 162
2021/2022581 11 109 4 14 26 6 6 211 5 23 76 90
2022/20231.113 89 109 20 93 88 119 0 63 484 3 35 10
2023/2024365 32 45 30 9 3 1 125 28 71 4 17 0
Totale 3.519